ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Nephro Care India Limited submitted its Statement of Deviation or Variation regarding IPO issue proceeds for the quarter ending June 30, 2026, confirming no deviations.
Nephro Care India Limited disclosed related party transactions for the half year ended March 31, 2026. The filing complies with SEBI's routine regulatory disclosure requirements.
Nephro Care India Limited submitted its Structured Digital Database (SDD) Compliance Certificate for the quarter ended March 31, 2026. The certificate, issued by Saptasikha & Co., confirms the company maintained a non-tamperable database for capturing UPSI events in compliance with SEBI (Prohibition of Insider Trading) Regulations.
Nephro Care India Limited informed the exchange that Corporate Governance provisions under Regulation 27(2) of SEBI LODR are not applicable to it. As an SME-listed entity on the NSE EMERGE platform, the company is exempt from these requirements for the quarter and year ended March 31, 2026.